SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-026876
Filing Date
2022-02-24
Accepted
2022-02-24 21:24:03
Documents
2
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm227622-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm227622-3_4seq1.xml 4 6868
2 EXHIBIT 24 tm227622d3_ex24.htm EX-24 7292
  Complete submission text file 0001104659-22-026876.txt   15595
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Hudson Frederick M. (Reporting) CIK: 0001438462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 22674068